152 related articles for article (PubMed ID: 1680495)
1. Clonal granulocytes and bone marrow cells in the cellular phase of agnogenic myeloid metaplasia.
Kreipe H; Jaquet K; Felgner J; Radzun HJ; Parwaresch MR
Blood; 1991 Oct; 78(7):1814-7. PubMed ID: 1680495
[TBL] [Abstract][Full Text] [Related]
2. Clonal analysis of agnogenic myeloid metaplasia.
Kreipe H; Jaquet K; Felgner J; Parwaresch MR
Leuk Lymphoma; 1992 Dec; 8(6):459-64. PubMed ID: 1363649
[TBL] [Abstract][Full Text] [Related]
3. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Dolgikh TY; Senchukova SR; Vinogradova EV; Krinitsyna YM
Bull Exp Biol Med; 2020 Apr; 168(6):734-738. PubMed ID: 32333309
[TBL] [Abstract][Full Text] [Related]
4. Cellular composition and reticulin fibrosis in chronic myeloid leukaemia.
Ghosh K; Varma N; Varma S; Dash S
Indian J Cancer; 1988 Sep; 25(3):128-35. PubMed ID: 3224984
[No Abstract] [Full Text] [Related]
5. [Histopathology and molecular pathology of chronic myeloproliferative disorders].
Kreipe HH
Veroff Pathol; 1993; 141():1-158. PubMed ID: 8372486
[TBL] [Abstract][Full Text] [Related]
6. Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia.
Ohsaka A; Miura Y; Takahashi A; Yokoyama T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(6):399-405. PubMed ID: 1683056
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
[TBL] [Abstract][Full Text] [Related]
8. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
9. Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia.
Hyun BH; Gulati GL; Ashton JK
Clin Lab Med; 1990 Dec; 10(4):825-38. PubMed ID: 2272176
[TBL] [Abstract][Full Text] [Related]
10. Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis.
Jacobson RJ; Salo A; Fialkow PJ
Blood; 1978 Feb; 51(2):189-94. PubMed ID: 620081
[TBL] [Abstract][Full Text] [Related]
11. Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features.
Thiele J; Hoeppner B; Zankovich R; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1989; 415(3):191-202. PubMed ID: 2503923
[TBL] [Abstract][Full Text] [Related]
12. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement.
Tsukamoto N; Morita K; Maehara T; Okamoto K; Sakai H; Karasawa M; Naruse T; Omine M
Br J Haematol; 1994 Feb; 86(2):253-8. PubMed ID: 7911034
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis.
Beham-Schmid C; Apfelbeck U; Sill H; Tsybrovsky O; Höfler G; Haas OA; Linkesch W
Blood; 2002 Jan; 99(1):381-3. PubMed ID: 11756197
[TBL] [Abstract][Full Text] [Related]
14. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
Thiele J; Kvasnicka HM
Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
[TBL] [Abstract][Full Text] [Related]
15. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
16. Increased erythrocytic and neutrophilic progenitors in myelofibrosis with myeloid metaplasia.
Ohl S; Carsten AL; Chanana AD; Chikkappa G; Cronkite EP
Eur J Cancer (1965); 1976 Feb; 12(2):131-5. PubMed ID: 1063073
[No Abstract] [Full Text] [Related]
17. Increased granulocytic, erythrocytic, and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia.
Chikkappa G; Carsten AL; Chanana AD; Chandra P; Cronkite EP
Am J Hematol; 1978; 4(2):121-31. PubMed ID: 677118
[TBL] [Abstract][Full Text] [Related]
18. [Parameters of granulocyte proliferation in chronic myeloid leukemia and their prognostic value].
Kote'lnikov VM; Khoroshko ND
Gematol Transfuziol; 1989 Aug; 34(8):7-10. PubMed ID: 2583453
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.
Martyré MC
Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621
[TBL] [Abstract][Full Text] [Related]
20. Histo- and immunomorphometry of megakaryopoiesis in chronic myeloid leukemia with myelofibrosis and so-called primary (idiopathic) osteo-myelofibrosis/-sclerosis.
Thiele J; Steinberg T; Hoeppner B; Wienhold S; Wagner S; Dienemann D; Fischer R
Anal Cell Pathol; 1990 Jul; 2(4):215-27. PubMed ID: 2275869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
